TCR Vaccines for Active Immunotherapy of T Cell Malignancies

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5516-5527

  Okada, Craig Y ^a   Wong, Carmen P ^a   Denney, Dan W ^b   Levy, Ronald ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Genitope Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL; RECOMBINANT VACCINE;

ANIMAL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CD8+ T LYMPHOCYTE; FEMALE; GENETIC TRANSFECTION; GENETICS; IMMUNIZATION; IMMUNOLOGY; MOUSE; T CELL LYMPHOMA; TIME;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION; LYMPHOMA, T-CELL; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOLS; RECEPTORS, ANTIGEN, T-CELL; TIME FACTORS; TRANSFECTION; VACCINES, SYNTHETIC;

EID: 0031296663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Lynch, R. C., R. J. Craff, S. Sirishinha, E. S. Simms, and H. N. Eisen. 1972. Myeloma proteins as tumor-specific transplantation antigens. Proc. Natl. Acad. Sci. USA 69:1540.
2. F1 mice. J. Exp. Med. 140:1547.
3. Freedman, P. M., J. R. Autry, S. Tokuda, and R. C. Williams. 1976. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein. J. Natl. Cancer Inst. 56:735.
4. Campbell, M. J., L. Esserman, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumor-derived IgM and its molecular subunits. J. Immunol. 139:2825.
5. George, A. J. T., S. G. Folkard, T. J. Hamblin, and F. K. Stevenson. 1988. Idiotype vaccination as a treatment for B cell lymphoma. J. Immunol. 141:2168.
6. Dyke, R. J., H. McBride, A. J. George, T. J. Hamblin, and F. K. Stevenson. 1991. Idiotypic vaccination against B-cell lymphoma leads to dormant tumour. Cell. Immunol. 132:70.
7. Stevenson, F. K., and J. Gordon. 1983. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. J. Immunol. 130:970.
8. Campbell, M. J., L. Esserman, N. E. Byars, A. C. Allison, and R. Levy. 1990. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145:1029.
9. Kwak, L. W., M. J. Campbell, A. D. Zelenetz, and R. Levy. 1990. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin. Blood 76:2411.
10. Kwak, L. W., M. J. Campbell, A. D. Zelenetz, and R. Levy. 1991. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy. Blood 78:2768.
11. Kaminski, M. S., K. Kitamura, D. G. Maloney, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: inhibition of tumor immunity by free idiotype protein. J. Immunol. 138:1289.
12. Tao, M. H., and R. Levy. 1993. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755.
13. Hawkins, R. E., G. Winter, T. J. Hamblin, F. K. Stevenson, and S. J. Russell. 1993. A genetic approach to idiotypic vaccination. J. Immunother. 14:273.
14. Stevenson, F. K., D. Zhu, C. A. King, L. J. Ashworth, S. Kumar, and R. E. Hawkins. 1995. Idiotypic DNA vaccines against B-cell lymphoma. Immunol. Rev. 145:211.
15. Syrengelas, A. D., T. T. Chen, and R. Levy. 1996. DNA immunization induces protective immunity against B cell lymphoma. Nat. Med. 2:1038.
16. Hakim, L, S. Levy, and R. Levy. 1996. A nine-amino acid peptide from IL-1β augments antitumor immune responses induced by protein and DNA vaccines. J. Immunol. 157:5503.
17. Kwak, L. W., M. J. Campbell, D. K. Czerwinski, S. Hart, R. A. Miller, and R. Levy. 1992. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327:1209.
18. Hsu, F. J., C. B. Caspar, L. W. Kwak, T. Liles, D. Czerwinski, B. Taidi, and R. Levy. 1995. Results of a clinical trial of idiotype specific vaccine therapy for B cell lymphoma. Blood 86:273.
19. Hsu, F. J., C. Benike, F. Fagnoni, T. M. Liles, D. Czerwinski, B. Taidi, E. G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:52.
20. Hsu, F., C. Casper, D. Czerwinski, L. Kwak, T. Liles, A. Syrengelas, B. Taidi-Laskowski, and R. Levy. 1997. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma: long-term results of a clinical trial. Blood 89:3129.
21. Hawkins, R. E., D. Zhu, M. Ovecka, R. G. Winte, T. J. Hamblin, A. Long, and F. K. Stevenson. 1994. Idiotypic vaccination against human B-cell lymphoma: rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83:3279.
22. Barth, R. K., B. S. Kim, N. C. Lan, T. Hunkapiller, N. Sobieck, A. Winoto, H. Gershenfeld, C. Okada, D. Hansburg, I. L. Weissman, and L. Hood. 1985. The murine T-cell receptor uses a limited repertoire of expressed Vβ gene segments. Nature 316:517.
23. Maecker, H. T. 1989. Prevalence of antigen receptor variants in human T cell lines and tumors. J. Immunol. 142:1395.
24. Ashwell, J. D., D. L. Longo, and S. H. Bridges. 1987. T-cell tumor elimination as a result of T-cell receptor-mediated activation. Science 237:61.
25. Kanagawa, O. 1989. In vivo T cell tumor therapy with monoclonal antibody directed to the Vβ chain of T cell antigen receptor. J. Exp. Med. 170:1513.
26. Janson, C. H., M. J. Tehrani, H. Mellstedt, and H. Wigzell. 1989. Anti-idiotype monoclonal antibody to a T-cell chronic lymphatic leukemia. Cancer Immunol. Immunother. 28:225.
27. H locus. Int. Immunol. 5:647.
28. Allison, J. P., B. W. McIntyre, and D. J. Bloch. 1982. Tumor-specific antigen of murine T cell lymphoma cells defined with monoclonal antibody. J. Immunol. 129:2293.
29. Ghose, T., and A. Guclu. 1974. Cure of a mouse lymphoma with radio-iodinated antibody. Eur. J. Cancer 10:787.
30. Hyman, R., and V. Stalling. 1974. Complementation patterns of Thy 1 variants and evidence that antigen loss variants "pre-exist" in the parental population. J. Natl. Cancer Inst. 51:429.
31. Holzmann, B., B. W. McIntyre, and I. L. Weissman. 1989. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell 56:37.
32. Palmer, M. S., A. Bentley, K. Gould, and A. R. Townsend. 1989. The T cell receptor from an influenza-A specific murine CTL clone. Nucleic Acids Res. 17:2353.
33. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and W. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J. Immunol. 142:2736.
34. Becker, M. L., R. Near, M. Mudgett-Hunter, M. N. Margolies, R. T. Kubo, J. Kaye, and S. M. Hedrick. 1989. Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Cell 58:911.
35. Koke, J. A., M. Yang, D. J. Henner, J. J. Volwerk, and O. H. Griffith. 1991. High-level expression in Escherichia coli and rapid purification of phosphatidylinositol-specific phospholipase C from Bacillus cereus and Bacillus thuringiensis. Protein Expression Purification 2:51.
36. Russel, M., S. Kidd, and M. R. Kelley. 1986. An improved filamentous helper phage for generating single-stranded plasmid DNA. Gene 45:333.
37. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367.
38. Moran, P., H. Raab, W. J. Kohr, and I. W. Caras. 1991. Glycophospholipid membrane anchor attachment. J. Biol. Chem. 266:1250.
39. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:475.
40. Peto, R., and J. Peto. 1972. Asymptomatically efficient rank invariant test procedures. J. R. Stat. Soc. 135:185.
41. O'Neill, H. C. 1991. Radiation leukemia virus-induced T-cell lymphomas with common T-cell receptor variable region structure and similar binding specificity for retrovirus. Leukemia 5:921.
42. Kanagawa, O., E. Palmer, and J. Bill. 1989. The T cell receptor Vβ6 domain imparts reactivity to the Mis-la antigen. Cell. Immunol. 119:412.
43. Lin, A. L., B. Devaux, A. Green, C. Sagerstrom, J. F. Elliot, and M. M. Davis. 1990. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 249:677.
44. Okayama, H., and P. Berg. 1983. A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells. Mol. Cell. Biol. 3:280.
45. Takebe, Y., M. Seiki, J.-I. Fujisawa, P. Hoy, K. Yokota, K.-I. Arai, M. Yoshida, and N. Arai. 1988. SRa promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.
46. Lopata, M. A., D. W. Cleveland, and B. Sollner-Webb. 1984. High-level expression of a chloramphenicol acetyltransferase gene by DEAE-dextran-mediated DNA transfection coupled with a dimethysulfoxide or glycerol shock treatment. Nucleic Acids. Res. 12:5707.
47. Jakobovits, A., G. J. Vergara, J. L. Kennedy, J. F. Hales, R. P. McGuinness, D. E. Casentini-Borocz, D. G. Brenner, and G. R. Often. 1993. Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production. Proc. Natl. Acad. Sci. USA 90:2551.
48. Traunecker, A., B. Dolder, F. Oliven, and K. Karjalainen. 1989. Solubilizing the T-cell receptor problems in solution. Immunol. Today 10:29.
49. Caras, I. W., M. A. Davitz, L. Rhee, G. Weddell, D. W. J. Martin, and V. Nussenzweig. 1987. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545.
50. Caras, I. W., G. N. Weddell, M. A. Davitz, V. Nussenzweig, and D. W. J. Martin. 1987. Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science 238:1280.
51. Kuhrober, A., R. Schirmbeck, and J. Reimann. 1994. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL. Eur. J. Immunol. 24:1172.
52. Meeker, T., J. Lowder, M. L. Cleary, S. Stewart, R. Warnke, J. Sklar, and R. Levy. 1985. Emergence of idiotype variants during therapy of B cell lymphoma with anti-idiotype antibodies. N. Engl. J. Med. 312:1658.
53. Brown, S. L., R. A. Miller, S. J. Horning, D. Czerwinski, S. M. Hart, R. McElderry, T. Basham, R. A. Warnke, T. C. Merigan, and R. Levy. 1989. Treatment of B cell lymphoma with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651.
54. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinmann. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
55. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.
56. Owhashi, M., and E. Heber-Katz. 1989. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein. J. Exp. Med. 168:2153.
57. Hashim, G. A., A. A. Vandenbark, A. B. Galang, T. Diamanduros, E. Carvalho, J. Srinivasan, R. Jones, M. Vainiene, W. J. Morrison, and H. Offner. 1990. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:4621.
58. Offner, H., A. G. Hashim, and A. A. Vandenbark. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430.
59. Howell, M. D., S. T. Winters, T. Olee, H. C. Powell, D. J. Carlo, and S. W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668.
60. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
61. Chunduru, S. K., R. M. Sutherland, G. A. Stewart, R. W. Doms, and Y. Paterson. 1996. Exploitation of the Vβ8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. J. Immunol. 156:4940.